SeaSpine Launches Cambria(TM) NanoMetalene(R) Interbody Device

VISTA, Calif., Oct 16, 2015 (GLOBE NEWSWIRE via COMTEX) —

SeaSpine Holdings Corporation SPNE, -3.72% a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the launch of its Cambria™ NanoMetalene® cervical interbody body fusion device.

Cambria NanoMetalene is indicated for use as an adjunct to fusion in patients with degenerative disc disease (DDD) and accompanies SeaSpine®’s growing portfolio of devices offering this proprietary technology.

In a presentation during NASS, Dr. James Bruffey, orthopedic spine surgeon in San Diego, commented on the topic of bond strength of NanoMetalene and indicated that destructive testing as well as insertion and push-out testing demonstrated no delamination of our atomic deposition titanium surface.

Cambria NanoMetalene offers the benefits associated with traditional PEEK-OPTIMA devices such as a modulus of elasticity similar to bone [1] and radiolucency for postoperative imaging, which allows surgeons to view the operative area and determine the extent of fusion of the vertebral bodies [2] . With a molecularly bonded titanium surface on an uncompromised PEEK-OPTIMA implant [2,3] , SeaSpine provides customers an interbody solution offering  the best of both materials.

“SeaSpine is committed to leveraging this unique technology and delivering interbodies that provide an optimal environment for fusion,” said Keith Valentine, CEO of SeaSpine. “We are excited to now add Cambria NanoMetalene to the portfolio for cervical procedures.”

SeaSpine has received FDA 510(k) clearance for other NanoMetalene-coated PEEK interbody devices in its current portfolio and expects to continue launching additional products with this technology throughout the next year.


SeaSpine is a global medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. SeaSpine has a comprehensive portfolio of orthobiologics and spinal fusion hardware solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures on the lumbar, thoracic and cervical spine. SeaSpine orthobiologics products consist of a broad range of advanced and traditional bone graft substitutes that are designed to improve bone fusion rates following a wide range of orthopedic surgeries, including spine, hip, and extremities procedures. The SeaSpine spinal fusion hardware portfolio consists of an extensive line of products to facilitate spinal fusion in minimally invasive surgery (MIS), complex spine, deformity and degenerative procedures. Expertise in both orthobiologic sciences and spinal fusion hardware product development allows SeaSpine to offer its surgeon customers a differentiated portfolio and a complete solution to meet their fusion requirements. SeaSpine currently markets its products through a network of independent sales agents in the United States and through stocking distributors in over 30 countries worldwide. Read more about SeaSpine at the company’s website, www.seaspine.com.

Print Friendly, PDF & Email

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button